NCT07418814

Brief Summary

This randomized controlled trial investigates the effectiveness of infant massage in reducing symptoms of immobilization-related lymphedema and improving comfort in preterm newborns hospitalized in the Neonatal Intensive Care Unit (NICU). Preterm infants frequently develop lymphedema due to their immature circulatory systems and prolonged lack of movement. The study compares two groups of infants: one receiving standard care and another receiving a daily 15-minute massage therapy session for 14 consecutive days in addition to standard care. Researchers will evaluate the impact of the massage by measuring the circumference of the infants' wrists, elbows, ankles, and knees to assess fluid reduction. Additionally, the infants' comfort levels will be assessed using the Premature Infant Comfort Scale (PICS). The goal is to determine if massage can serve as a safe, non-invasive method to manage lymphedema and reduce distress in this vulnerable population.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
9mo left

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Apr 2026Apr 2027

First Submitted

Initial submission to the registry

February 4, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

3 months

First QC Date

February 4, 2026

Last Update Submit

February 11, 2026

Conditions

Keywords

Infant MassagePreterm InfantLymphedemaNeonatal ComfortMassage TherapyImmobilization

Outcome Measures

Primary Outcomes (2)

  • Change in Extremity Circumference

    Circumference measurements of the upper and lower extremities (specifically the wrist, elbow, ankle, and knee) will be taken using a non-elastic tape measure. Measurements are recorded in centimeters to assess the reduction of fluid accumulation. A decrease in circumference indicates improvement in lymphedema symptoms.

    Baseline (Day 0), Day 7, and Day 14

  • Change in Pitting Edema Grade

    Pitting edema severity is assessed by applying gentle pressure to the edematous area for 5 seconds and observing the depth and duration of the indentation (pitting). It is graded on a standard clinical scale (e.g., +1 to +4), where higher scores indicate more severe edema and lower scores indicate improvement.

    Baseline (Day 0), Day 7, and Day 14

Secondary Outcomes (4)

  • Change in Comfort Level (Premature Infant Comfort Scale)

    Baseline (Day 0), Day 7, and Day 14 (Assessed before and after the intervention)

  • Change in Heart Rate

    Baseline (Day 0), Day 7, and Day 14 (Measured before, during, and after intervention)

  • Change in Oxygen Saturation

    Baseline (Day 0), Day 7, and Day 14 (Measured before, during, and after intervention)

  • Change in Body Temperature

    Baseline (Day 0), Day 7, and Day 14 (Measured before, during, and after intervention)

Study Arms (2)

Infant Massage Group

EXPERIMENTAL

The massage application consists of gentle tactile stimulation targeting the extremities and lymphatic drainage pathways. The therapy is performed for 15 minutes once daily for 14 days by a trained researcher/nurse. The technique is adapted for preterm physiology to ensure safety and comfort.

Behavioral: Infant Massage Group

Control Group

NO INTERVENTION

Routine clinical management provided to preterm infants in the NICU, including standard medical treatment, feeding, positioning, and hygiene care according to the unit's protocols.

Interventions

The intervention involves a standardized infant massage therapy protocol applied by a trained researcher. The massage consists of gentle tactile stimulation targeting the upper and lower extremities to facilitate lymphatic drainage. The sessions are conducted for 15 minutes, once daily, for a period of 14 consecutive days. This intervention is provided in addition to standard NICU care.

Infant Massage Group

Eligibility Criteria

Age28 Weeks - 37 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • To ensure a homogenous and clinically stable sample, infants meeting the following criteria will be recruited:
  • Clinical diagnosis of lymphedema.
  • Hemodynamic and clinical stability.
  • No current or recent (within 24 hours) administration of analgesic or sedative medications that could mask comfort assessments.
  • Intact skin integrity with no contraindications for topical massage.
  • Absence of congenital heart disease or neurological disorders (antenatal or postnatal diagnosis).
  • No immediate requirement for endotracheal aspiration.
  • Requirement for only non-invasive respiratory support (e.g., nCPAP).
  • Provision of written informed consent by the legal guardians (parents).

You may not qualify if:

  • Infants will be excluded if they present with:
  • Major congenital anomalies.
  • Severe respiratory, cardiac, or neurological instability during the study period.
  • Any acute medical contraindication identified by the attending neonatologist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

LymphedemaPremature BirthEdema

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ayşe Gürol, PhD

    Erzurum Technical University

    STUDY DIRECTOR

Central Study Contacts

Birgül Tuncay, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 4, 2026

First Posted

February 18, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

April 1, 2027

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to privacy laws and ethical restrictions.